Yongxiang Gao

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Pulmonary Fibrosis

Reactive Oxygen Species

Top Venues

Oxidative medicine and cellular longevity

BMC complementary and alternative medicine

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Huan Yao, Qian Xie, Qingman He, Lei Zeng, Jing Long, Yuanyuan Gong, Xueping Li, Xueping Li, Weiwei Liu, Zhiyi Xu, Huihui Wu, Chuan Zheng, Yongxiang Gao
Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity. Oxidative medicine and cellular longevity 2022 (2022)
Huan Yao, Shujun Wei, Yongjing Xiang, Ziqiang Wu, Weiwei Liu, Baojia Wang, Xueping Li, Huan Xu, Juan Zhao, Yongxiang Gao
Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Xueping Li, Guangmin Xu, Shujun Wei, Baocheng Zhang, Huan Yao, Yuchi Chen, Weiwei Liu, Baojia Wang, Juan Zhao, Yongxiang Gao
Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling. BMC complementary and alternative medicine 19 (1) (2019)